PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lenacil | 218-499-0 | 2164-08-1 | - | - | - | - | - | 1 | - | - | - | Details |
|
Lavender, Lavandula hybrida, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Lavandula hybrida, Labiatae.
|
294-470-6 | 91722-69-9 | - | - | - | - | - | 1 | - | - | - | Details |
| L-p-mentha-1(6),8-dien-2-one | 229-352-5 | 6485-40-1 | - | - | 1 | - | 1 | 1 | - | - | - | Details |
| L-(+)-lactic acid | 201-196-2 | 79-33-4 | - | - | 3 | - | - | 1 | - | - | - | Details |
| isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea | 251-835-4 | 34123-59-6 | - | - | - | - | - | 1 | - | - | - | Details |
| Isopropyl-(2E,4E,7S)-11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate | 613-834-0 | 65733-16-6 | - | - | - | - | - | 1 | - | - | - | Details |
|
isoeugenol [1]; (E)-2-methoxy-4-(prop-1-enyl)phenol [2]; (Z)-2-methoxy-4-(prop-1-enyl)phenol [3]
show/hide
|
- | - | - | - | - | - | - | 1 | - | - | - | Details |
| Isobutyl methacrylate | 202-613-0 | 97-86-9 | - | - | 2 | - | 1 | 1 | - | - | - | Details |
| Iprovalicarb (ISO); isopropyl [(2S)-3-methyl-1-{[1-(4-methylphenyl)ethyl]amino}-1-oxobutan-2-yl]carbamate | 604-209-3 | 140923-17-7 | - | - | - | - | - | 1 | - | - | - | Details |
| iprodione (ISO); 3-(3,5-dichlorophenyl)-N-isopropyl-2,4-dioxoimidazolidine-1-carboxamide | 253-178-9 | 36734-19-7 | - | - | - | - | - | 1 | - | - | - | Details |